ArticleCancer immunology, immunotherapy : CII2026

BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia.

Chiara Badami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.